๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This randomized phase III trial studies combination chemotherapy with blina...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-05-19
Trial ID
NCT02003222
Treatments Being Tested
The purpose of this study is to demonstrate comparability of the ORR in pat...
Status
Completed
Location
Investigative site
Start Date
2011-12-01
Trial ID
NCT01419665
This phase II/III trial tests whether it is possible to decrease the chance...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-10-22
Trial ID
NCT03984448
This phase II/III trial tests adding glofitamab to standard of care chemoim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-30
Trial ID
NCT07724457
Treatments Being Tested
This phase II trial tests the safety, best dose, and effectiveness of epcor...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-12-07
Trial ID
NCT07097363
This phase II trial tests how well tafasitamab and rituximab works for the ...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-10-31
Trial ID
NCT07731789
This randomized phase II trial studies how well rituximab and combination c...
Status
Active Not Recruiting
Location
Alaska Breast Care and Surgery LLC
Start Date
2013-08-27
Trial ID
NCT01856192
This phase II trial tests the effectiveness of golcadomide and rituximab as...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-04-02
Trial ID
NCT06834373
This phase II trial tests how well epcoritamab in combination with rituxima...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-07-27
Trial ID
NCT07365306
This phase I trial studies the safety and side effects of glofitamab plus a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-09
Trial ID
NCT07649304